Results 71 to 80 of about 8,702,161 (252)

GCARDTI: Drug–target interaction prediction based on a hybrid mechanism in drug SELFIES

open access: yesQuantitative Biology
The prediction of the interaction between a drug and a target is the most critical issue in the fields of drug development and repurposing. However, there are still two challenges in current deep learning research: (i) the structural information of drug ...
Yinfei Feng   +3 more
doaj   +1 more source

Mitigating cold-start problems in drug-target affinity prediction with interaction knowledge transferring

open access: yes, 2022
Predicting the drug-target interaction is crucial for drug discovery as well as drug repurposing. Machine learning is commonly used in drug-target affinity (DTA) problem.
Thin Nguyen (13097583)   +2 more
core  

Partial depletion of plasminogen activator inhibitor‐1 decreases subcutaneous fat cell hypertrophy and liver cholesterol in high‐fat‐fed female mice

open access: yesFEBS Letters, EarlyView.
Obesity raises blood levels of PAI‐1, a protein linked to metabolic dysfunction‐associated steatotic liver disease in people with obesity. In female mice fed a high‐fat diet, partially lowering PAI‐1 led to smaller subcutaneous fat cells and lower liver cholesterol, without changing body weight or insulin sensitivity.
Claudia E. Ramirez Bustamante   +10 more
wiley   +1 more source

Meta-Path-Based Probabilistic Soft Logic for Drug–Target Interaction Predictions

open access: yesMathematics
Drug–target interaction (DTI) predictions, which aim to predict whether a drug will be bounded to a target, have received wide attention recently. The goal is to automate and accelerate the costly process of drug design.
Shengming Zhang, Yizhou Sun
doaj   +1 more source

Ligand‐dependent transcriptional heterogeneity in cell cycle gene expression delays G1/S entry

open access: yesFEBS Letters, EarlyView.
EGF and HRG induce distinct G1/S progression programs in ErbB2‐amplified BT474 breast cancer cells. Despite activating the potent ErbB2–ErbB3 heterodimer, HRG does not accelerate cell‐cycle entry. Instead, EGF promotes earlier restriction‐point passage via ERK–FOS signaling, whereas HRG activates the AKT–MYC axis, driving transcriptional heterogeneity ...
Ririn Rahmala Febri   +5 more
wiley   +1 more source

A review of deep learning methods for ligand based drug virtual screening

open access: yesFundamental Research
Drug discovery is costly and time consuming, and modern drug discovery endeavors are progressively reliant on computational methodologies, aiming to mitigate temporal and financial expenditures associated with the process.
Hongjie Wu   +6 more
doaj   +1 more source

Biases of drug-target interaction network data

open access: yes, 2020
. Network based prediction of interaction between drug compounds and target proteins is a core step in the drug discovery process. The availability of drug-target interaction data has boosted the development of machine learning methods for the in silico ...
Twan Van Laarhoven, Elena Marchiori
core  

Synergistic perspectives—How single‐molecule biophysics complement biochemical understanding

open access: yesFEBS Letters, EarlyView.
In this review, we discuss how ensemble biochemistry and single‐molecule approaches are complementary, outline commonly used single‐molecule techniques, and illustrate their relevance through two representative case studies: chromatin organization by SMC complexes and pathway choice during DNA double‐strand break repair.
Sara De Bragança   +2 more
wiley   +1 more source

Translophagy—A potential link between autophagy impairment and translational errors

open access: yesFEBS Letters, EarlyView.
Neurodegenerative diseases are characterised by the accumulation of abnormal proteins and protein aggregates, but their origin often remains unknown. We propose that selective autophagy removes damaged protein‐making machinery, preventing errors during protein synthesis.
Mykola V. Korolchuk   +11 more
wiley   +1 more source

The processes of reform in Victoria’s alcohol and other drug sector, 2011-2014 [PDF]

open access: yes, 2014
This paper explores issues and concerns related to the 2014 alcohol and other drug sector recommissioning process in Victoria. Overview In mid-2014, the Victorian Alcohol and Drug Association approached the Drug Policy Modelling Program, at the ...
Drug Policy Modelling Program
core  

Home - About - Disclaimer - Privacy